Transphorm Q2 2023 Results: Revenues Exceed Expectations, EPS In Line
Transphorm (NASDAQ:TGAN) Second Quarter 2023 Results
Main financial results
- Revenue: $3.67 million (down 68% from Q2 2022).
- Net loss: $6.00 million (down 200% from profit of $5.98 million in Q2 2022).
- Loss of $0.11 per share (vs. profit of $0.14 in 2Q 2022).
All figures shown in the table above are for the 12 month period (TTM)
Transphorm revenue overview
Going forward, revenue is expected to grow 51% per year on average over the next 3 years, compared to a growth forecast of 7.1% for the US semiconductor industry.
Performance of the American semiconductor industry.
Shares of the company are down 1.5% from a week ago.
It must be said that we discovered 3 warning signs for Transphorm which you should be aware of before investing here.
Valuation is complex, but we help make it simple.
Find out if Transform is potentially overvalued or undervalued by viewing our full analysis, which includes fair value estimates, risks and warnings, dividends, insider trading and financial health.
See the free analysis
Feedback on this article? Concerned about content? Get in touch with us directly. You can also email the editorial team (at) Simplywallst.com.
This Simply Wall St article is general in nature. We provide commentary based on historical data and analyst forecasts only using unbiased methodology and our articles are not intended to be financial advice. It is not a recommendation to buy or sell stocks and does not take into account your objectives or financial situation. Our goal is to bring you targeted long-term analysis based on fundamental data. Note that our analysis may not take into account the latest announcements from price-sensitive companies or qualitative materials. Simply Wall St has no position in the stocks mentioned.